Anti-CD20 therapies, a type of MS treatment, changes levels and profiles of several immune cells in people with MS, a study ...

A trial using PET scans to test the anti-inflammatory drug PIPE-791 finished enrolling healthy volunteers and patients with ...

When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...

A former GP is facing jail after conducting “unnecessary” genital examinations on patients, including two teenage boys.

Panelists discuss how progression independent of relapse activity (PIRA) represents a distinct pathological process involving ...

Rocky Mountain MS clinic, a Salt Lake City-based provider of specialized care for people living with multiple sclerosis, has ...

To quantify antibiotics in ICU patients’ blood, dried blood spot analysis was sued alongside UHPLC–MS/MS to monitor these substances in a more convenient matter.

Panelists discuss how robust clinical evidence from major studies like the EPIC and OPERA trials demonstrates that ...

UC Riverside study may lead to new treatments for multiple sclerosis. Multiple sclerosis (MS) affects an estimated 2.3 ...

Patients will be given more control of their health via the NHS app, while there will be less reliance on hospitals, the plan says.

Edmondson has been the lead investigator on or participated on research teams behind more than 50 clinical studies showing ...

New PIP claimants risk losing out on up to £110.40 a week – or £5,740 a year – the amount that someone with an enhanced daily ...